With a UK trial for Rituximab at least temporarily in doubt, let’s turn the focus to Ampligen – a drug that is potentially one trial away from being approved for ME/CFS. Ampligen is still the only drug that’s been able to move the needle on exercise in ME/CFS.
With NIH director Collins making noises about a possible Ampligen trial and a new review paper out, it’s time to make the case for Ampligen.
Check out a Simmaron Research Foundation sponsored blog:
Tell us how your coronavirus vaccination went and find out how other people with ME/CFS and/or FM fared with their coronavirus vaccination in Health Rising’s Coronavirus Vaccine Side Effects Poll.